8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (date of earliest event reported): July 31, 2007

DAVITA INC.

(Exact name of registrant as specified in its charter)

Delaware	1-14106	No. 51-0354549
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

601 Hawaii Street

El Segundo, CA 90245

(Address of principal executive offices including Zip Code)

(310) 536-2400

(Registrant’s telephone number, including area code)

Not applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 240.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13c-4)

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On July 31, 2007, the Board of Directors (the “Board”) of DaVita Inc. (the “Company”) elected Paul J. Diaz as a member of the Board. The Board has not yet determined the committees of the Board to which Mr. Diaz may be appointed. A copy of the press release announcing the election of Mr. Diaz is attached hereto as Exhibit 99.1.

Pursuant to the Company’s Director Compensation Philosophy and Plan (the “Plan”), Mr. Diaz will receive an initial grant of options to purchase 15,000 shares of the Company’s stock in connection with his election to the Board. Mr. Diaz will receive the standard compensation amounts payable to non-employee directors of the Company as set forth in the Plan. The foregoing description of the Plan is qualified in its entirety by reference to the Plan which was filed with the Company’s Current Report on Form 8-K on July 31, 2006.

No arrangement or understanding exists between Mr. Diaz and any other person or persons pursuant to which he was selected as a director. The Company has not been a participant in any transaction since the beginning of its last fiscal year, and is not a participant in any currently proposed transaction, in which Mr. Diaz, or any member of his immediate family, has a direct or indirect material interest.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Exhibit Number	Description
99.1	Press Release of DaVita Inc., dated August 6, 2007.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	DAVITA INC.
Date: August 6, 2007	By:	/s/ Joseph Schohl
		Joseph Schohl
		Vice President, General Counsel and Secretary

EXHIBIT INDEX

Exhibit Number	Description
99.1	Press Release of DaVita Inc., dated August 6, 2007.

EX-99.1

Exhibit 99.1

Contact:	LeAnne Zumwalt
	DaVita Inc.
	650 696-8910

Paul J. Diaz Joins DaVita Board of Directors

El Segundo, Calif., August 6, 2007, DaVita Inc. (NYSE:DVA) announced today that Paul J. Diaz has been appointed to the Company’s Board of Directors.

Mr. Diaz is the President and Chief Executive Officer of Kindred Healthcare, Inc., one of the largest providers of long-term healthcare services in the United States. Mr. Diaz joined Kindred in January 2002 as President and Chief Operating Officer. Mr. Diaz serves on the Boards of Kindred Healthcare, PharMerica Corporation, the Bloomberg School of Public Health at John Hopkins University and the Board of Visitors of Georgetown University Law Center.

Prior to joining Kindred, Mr. Diaz was the managing member of Falcon Capital Partners, LLC, a private investment and consulting firm and from 1996 to July 1998, Mr. Diaz served in various executive capacities with Mariner Health Group, Inc., including as Executive Vice President and Chief Operating Officer. Mr. Diaz is an attorney and accountant; he graduated from the Kogod College of Business Administration at the American University and received his law degree from Georgetown University.

“We look forward to Mr. Diaz’s service on the Board. He brings a wealth of experience in the healthcare industry and his broad experience and expertise will further strengthen our Board,” stated Peter Grauer, Lead Independent Director and Kent Thiry, Chairman and CEO.

DaVita is a leading provider of dialysis services for patients suffering from chronic kidney failure. The Company provides services at kidney dialysis centers and home peritoneal dialysis programs domestically in 42 states, as well as Washington D.C. As of June 30, 2007, DaVita operated or managed 1,321 outpatient facilities serving approximately 106,000 patients.